Innorna Advances Mrna Therapy For Chronic Metabolic Diseases
17 Mar 2026 //
PR NEWSWIRE
INNORNA Completes Phase II for Bivalent RSV mRNA Vaccine IN006
10 Sep 2025 //
BUSINESSWIRE
Innorna gets FDA Rare Pediatric Disease, Orphan Drug Designations
27 Apr 2025 //
BUSINESSWIRE

Market Place
Sourcing Support